Abbreviated Assessment
An abbreviated assessment is a less comprehensive assessment that focusses more specifically on the disease and treatments being studied.
An abbreviated assessment is a less comprehensive assessment that focusses more specifically on the disease and treatments being studied.
Support Provided by AbbVie, Amgen, AstraZeneca, Bristol Myers Squibb, Eisai, Genentech, Merck, and Sanofi.
